Zoetis Inc.
ZTSAPI behind this page
ZTS FY 2025 request
Playground key active
/api/financials?ticker=ZTS&year=2025&quarter=4&full_year_mode=true
Pick an endpoint and run the request.
Income Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Revenue | 9,467 | 9,256 | +2.3% |
Show Product Lines breakouts |
|||
| Animal health diagnostics | 434 | 386 | +12.4% |
| Anti-infectives | 1,036 | 1,100 | -5.8% |
| Cattle | 1,492 | 1,531 | -2.5% |
| Companion Animal | 6,587 | 6,278 | +4.9% |
| Companion Animal · International Segment | 2,367 | 2,224 | +6.4% |
| Companion Animal · United States Segment | 4,220 | 4,054 | +4.1% |
| Contract Manufacturing and Human Health Diagnostics [Member] | 116 | 80 | +45.0% |
| Dermatology [Member] | 1,754 | 1,655 | +6.0% |
| Dogs and Cats | 304 | 285 | +6.7% |
| Fish | 286 | 242 | +18.2% |
| Horses | 6,283 | 5,993 | +4.8% |
| Livestock | 2,764 | 2,898 | -4.6% |
| Livestock · International Segment | 1,887 | 1,878 | +0.5% |
| Livestock · United States Segment | 877 | 1,020 | -14.0% |
| Manufactured Product Other | 88 | 82 | +7.3% |
| Medicated feed additives | 27 | 293 | -90.8% |
| Other non-pharmaceuticals | 263 | 253 | +4.0% |
| Other pharmaceuticals | 697 | 658 | +5.9% |
| Pain & Sedation | 840 | 851 | -1.3% |
| Parasiticides | 2,341 | 2,153 | +8.7% |
| Poultry | 432 | 527 | -18.0% |
| Swine | 466 | 516 | -9.7% |
| Total Products and Services | 9,351 | 9,176 | +1.9% |
| Vaccines | 1,959 | 1,827 | +7.2% |
Show Business Segments breakouts |
|||
| International Segment · Operating Segments | 998 | 937 | +6.5% |
| International Segment · Operating Segments | 4,254 | 4,102 | +3.7% |
| United States Segment · Operating Segments | 5,097 | 5,074 | +0.5% |
Show Geography breakouts |
|||
| AU | 329 | 319 | +3.1% |
| BR | 393 | 414 | -5.1% |
| CA | 290 | 277 | +4.7% |
| CL | 139 | 123 | +13.0% |
| CN | 227 | 270 | -15.9% |
| DE | 236 | 225 | +4.9% |
| ES | 145 | 130 | +11.5% |
| FR | 165 | 156 | +5.8% |
| GB | 325 | 314 | +3.5% |
| IT | 137 | 129 | +6.2% |
| JP | 154 | 147 | +4.8% |
| MX | 160 | 169 | -5.3% |
| Other developed markets | 641 | 564 | +13.7% |
| Other emerging markets | 913 | 865 | +5.5% |
| Total Geographical Area | 9,351 | 9,176 | +1.9% |
| US | 5,097 | 5,074 | +0.5% |
| Cost of Revenue | 2,666 | 2,719 | -1.9% |
Show Product Lines breakouts |
|||
| Shipping And Handling | 102 | 107 | -4.7% |
Show Business Segments breakouts |
|||
| International Segment · Operating Segments | 1,312 | 1,312 | 0.0% |
| United States Segment · Operating Segments | 842 | 936 | -10.0% |
| Selling, General & Administrative | 2,378 | 2,318 | +2.6% |
| Research And Development Expense Excluding Acquired In Process Cost | 698 | 686 | +1.7% |
| Amortization Of Intangible Assets Not Associated With Single Function | 128 | 141 | -9.2% |
| Restructuring Charges And Acquisition And Divestiture Related Costs | 51 | 53 | -3.8% |
| Interest Expense | 222 | 225 | -1.3% |
| Non-Operating Income (Expense) | -36 | -19 | -89.5% |
Show Business Segments breakouts |
|||
| International Segment · Operating Segments | -1 | -1 | 0.0% |
| Income Before Taxes | 3,360 | 3,133 | +7.2% |
Show Business Segments breakouts |
|||
| All Other Segments | -562 | -562 | 0.0% |
| International Segment · Operating Segments | 2,264 | 2,118 | +6.9% |
| United States Segment · Operating Segments | 3,438 | 3,336 | +3.1% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -1,240 | -1,213 | -2.2% |
| Operating Segments | 5,702 | 5,454 | +4.5% |
Show Income Tax Authority breakouts |
|||
| Non Us | 1,483 | 1,266 | +17.1% |
| US | 1,877 | 1,867 | +0.5% |
| Income Tax Expense (Benefit) | 687 | 637 | +7.8% |
| Net Income | 2,673 | 2,496 | +7.1% |
Show Equity Components breakouts |
|||
| Retained Earnings | 2,673 | 2,486 | +7.5% |
| Net Income | 2,673 | 2,486 | +7.5% |
| EPS (Basic) | 6.03 | 5.47 | +10.2% |
| EPS (Diluted) | 6.02 | 5.47 | +10.1% |
| Wtd Avg Shares (Basic) | 443.44 | 454.2 | -2.4% |
| Wtd Avg Shares (Diluted) | 443.83 | 454.85 | -2.4% |
| Common Stock Dividends Per Share Cash Paid | 2.03 | 1.8 | +13.0% |
| Gross Profit (FY) | — | — | — |
Show Business Segments breakouts |
|||
| International Segment · Operating Segments | 2,942 | 2,790 | +5.4% |
| United States Segment · Operating Segments | 4,255 | 4,138 | +2.8% |
| Operating Expenses (FY) | — | — | — |
Show Business Segments breakouts |
|||
| International Segment · Operating Segments | 677 | 671 | +0.9% |
| United States Segment · Operating Segments | 817 | 805 | +1.5% |
| Other Non-Operating Income (Expense) | 6 | 4 | +50.0% |
| Comprehensive Income | 2,779 | 2,385 | +16.5% |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax | -19 | 4 | -575.0% |
| Foreign Currency Transaction Gain Loss Before Tax | 45 | 50 | -10.0% |
Balance Sheet
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Accounts Receivable | 1,590 | 1,316 | +20.8% |
| Inventory | 2,430 | 2,306 | +5.4% |
| Other Assets Current | 436 | 377 | +15.6% |
| Total Current Assets | 6,768 | 5,986 | +13.1% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 3,681 | 3,391 | +8.6% |
Show Geography breakouts |
|||
| Non Us | 1,225 | 1,142 | +7.3% |
| US | 2,456 | 2,249 | +9.2% |
| Operating Lease Right-of-Use Assets | 288 | 219 | +31.5% |
| Goodwill | 2,767 | 2,724 | +1.6% |
Show Geography breakouts |
|||
| Non Us | 1,252 | 1,209 | +3.6% |
| US | 1,515 | 1,515 | 0.0% |
| Deferred Tax Assets | 637 | 540 | +18.0% |
| Other Non-Current Assets | 328 | 250 | +31.2% |
| Total Assets | 15,467 | 14,237 | +8.6% |
| Intangible Assets | 784 | 918 | -14.6% |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Brands and tradenames | 112 | 121 | -7.4% |
| Developed Technology Rights | 590 | 716 | -17.6% |
| Other Intangible Assets | 82 | 81 | +1.2% |
| Other Assets | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 2,312 | 1,987 | +16.4% |
| Intangible Assets Net Excluding Goodwill | 998 | 1,127 | -11.4% |
| Current Liabilities | |||
| Accounts Payable | 487 | 433 | +12.5% |
| Dividends Payable Current | 232 | 224 | +3.6% |
| Accrued Liabilities | 852 | 746 | +14.2% |
| Employee Related Liabilities Current | 410 | 441 | -7.0% |
| Taxes Payable Current | 147 | 93 | +58.1% |
| Other Liabilities Current | 107 | 125 | -14.4% |
| Total Current Liabilities | 2,235 | 3,412 | -34.5% |
| Non-Current Liabilities | |||
| Long-Term Debt | 9,042 | 5,220 | +73.2% |
| Deferred Tax Liabilities | 139 | 167 | -16.8% |
| Operating Lease Liabilities | 196 | 174 | +12.6% |
| Accrued Income Taxes Noncurrent | 276 | 272 | +1.5% |
| Other Non-Current Liabilities | 248 | 222 | +11.7% |
| Total Liabilities | 12,136 | 9,467 | +28.2% |
| Stockholders' Equity | |||
| Common Stock | 5 | 5 | 0.0% |
| Treasury Stock Value | -10,685 | -7,445 | -43.5% |
| Additional Paid-In Capital | 1,101 | 1,182 | -6.9% |
| Retained Earnings | 13,744 | 11,968 | +14.8% |
| Accumulated Other Comprehensive Income | -834 | -940 | +11.3% |
| Total Stockholders' Equity | 3,331 | 4,770 | -30.2% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 3,331 | 4,770 | -30.2% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | 2 | — | — |
| Accumulated Gain Loss Net Cash Flow Hedge Parent | 70 | 89 | -21.3% |
| Accumulated Other Comprehensive Income | -834 | -940 | +11.3% |
| Accumulated Other Comprehensive Income Loss Derivative Qualifying As Hedge Excluded Component Including Portion Attributable To Noncontrolling Interest | -39 | 62 | -162.9% |
| Accumulated Translation Adjustment | -867 | -1,091 | +20.5% |
| Additional Paid In Capital | 1,101 | 1,182 | -6.9% |
| Common Stock | 5 | 5 | 0.0% |
| Retained Earnings | 13,744 | 11,968 | +14.8% |
| Treasury Stock Common | -10,685 | -7,445 | -43.5% |
| Total Liabilities & Equity | 15,467 | 14,237 | +8.6% |
Cash Flow Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 487 | 497 | -2.0% |
Show Business Segments breakouts |
|||
| All Other Segments | 51 | 43 | +18.6% |
| International Segment · Operating Segments | 100 | 96 | +4.2% |
| United States Segment · Operating Segments | 93 | 85 | +9.4% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 110 | 128 | -14.1% |
| Operating Segments | 193 | 181 | +6.6% |
| Stock-Based Compensation | 83 | 74 | +12.2% |
| Asset Impairment Charges | 47 | 31 | +51.6% |
Show Restructuring Cost And Reserve breakouts |
|||
| Facility Closing | 22 | — | — |
| Gain Loss On Sales Of Assets And Asset Impairment Charges | 3 | 23 | -87.0% |
| Inventory Write Down | 68 | 97 | -29.9% |
| Deferred Income Taxes | -52 | -338 | +84.6% |
| Increase Decrease In Derivative Assets And Liabilities | 11 | — | — |
| Other Non-Cash Items | -8 | -6 | -33.3% |
| Change in Accounts Receivable | -236 | -61 | -286.9% |
| Change in Inventory | -199 | -40 | -397.5% |
| Increase Decrease In Other Operating Assets | -165 | 52 | -417.3% |
| Change in Accounts Payable | 46 | 31 | +48.4% |
| Increase Decrease In Other Operating Liabilities | 85 | 114 | -25.4% |
| Increase Decrease In Accrued Taxes Payable | 61 | -17 | +458.8% |
| Net Cash from Operations | 2,904 | 2,953 | -1.7% |
| Investing Activities | |||
| Capital Expenditures | -621 | -655 | +5.2% |
| Payments To Acquire Business Two Net Of Cash Acquired | -24 | -8 | -200.0% |
| Payments To Acquire Investments | -7 | -5 | -40.0% |
| Payments For Proceeds From Hedge Investing Activities | -93 | 62 | -250.0% |
| Proceeds From Divestiture Of Businesses Net Of Cash Divested | -4 | 293 | -101.4% |
| Other Investing Activities | 1 | -2 | +150.0% |
| Net Cash from Investing | -748 | -315 | -137.5% |
| Financing Activities | |||
| Repayments Of Long Term Debt | -1,350 | — | — |
| Proceeds From Issuance Of Senior Long Term Debt | 1,848 | — | — |
| Proceeds From Convertible Debt | 2,000 | — | — |
| Debt Issuance Costs | -43 | — | — |
| Payments For Hedge Financing Activities | -187 | — | — |
| Share Based Compensation Related Proceeds Net Of Taxes Paid On Withholding Shares | -11 | -8 | -37.5% |
| Share Repurchases | -3,235 | -1,858 | -74.1% |
| Payments Of Ordinary Dividends | -889 | -786 | -13.1% |
| Proceeds From Payments For Other Financing Activities | -3 | — | — |
| Net Cash from Financing | -1,870 | -2,660 | +29.7% |
| Supplemental | |||
| Income Taxes Paid | 715 | 892 | -19.8% |
| Interest Paid | 261 | 274 | -4.7% |
| Unpaid Capital Expenditures | 4 | 3 | +33.3% |
| Excise Tax Accrued On Net Share Repurchases Not Yet Paid | 31 | 17 | +82.4% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 39 | -32 | +221.9% |
| Net Change in Cash | 325 | -54 | +701.9% |
Values in millions USD. Source: SEC EDGAR 10-K filing.